1. Home
  2. SPCB vs FEMY Comparison

SPCB vs FEMY Comparison

Compare SPCB & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.90

Market Cap

43.8M

Sector

Technology

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.87

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
FEMY
Founded
1988
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
51.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SPCB
FEMY
Price
$8.90
$0.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$18.00
$6.83
AVG Volume (30 Days)
73.4K
1.7M
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
$27.13
$147.19
P/E Ratio
$10.60
N/A
Revenue Growth
N/A
63.53
52 Week Low
$3.14
$0.31
52 Week High
$18.95
$1.80

Technical Indicators

Market Signals
Indicator
SPCB
FEMY
Relative Strength Index (RSI) 43.64 50.81
Support Level $8.64 $0.79
Resistance Level $9.92 $0.95
Average True Range (ATR) 0.49 0.07
MACD 0.04 -0.01
Stochastic Oscillator 28.62 25.89

Price Performance

Historical Comparison
SPCB
FEMY

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: